Lupin up 1.5% on deal with Italian firm
DALAL STREET SPIKES
| Lupin informed that the company signed an in-licensing agreement with ItalFarmaco, a leading Italian pharmaceutical company. |
| As per the agreement, the company would exclusively market their cardiovascular critical care product, Enoxaparin Sodium Injection, in pre-filled syringes under the brand name `Lupenox` in the Indian market. |
| Earlier in March 2006, Lupin's wholly-owned subsidiary, Lupin pharmaceuticals, entered into an agreement with Chester Valley Pharmaceuticals, United States, to promote Atopiclair Nonsteroidal Cream to pediatricians. |
| In February, Lupin and Aspen Pharmacare Holdings of South Africa signed a memorandum of understanding to establish a 50:50 joint venture for the development, manufacture and global marketing (except US, South Africa & India Trade) of select anti-TB products. |